Pa. Court Sides With J&J In Risperdal Marketing Suit
A Pennsylvania appeals court on Thursday affirmed the dismissal of the commonwealth of Pennsylvania's suit alleging that Johnson & Johnson unit Janssen Pharmaceuticals Inc. had improperly marketed the antipsychotic drug Risperdal....To view the full article, register now.
Already a subscriber? Click here to view full article